Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.3%
Fri, 6 Sep 9:34

MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.3%Image source: Eoneren/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 7% and is presently trading at Rs 276.8.

Meanwhile, the BSE HEALTHCARE index is at 43,710.8 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are ASTRAZENECA PHARMA (up 3.5%) and ERIS LIFESCIENCES (up 3.1%).

KIMS (down 1.1%) and CAPLIN POINT (down 1.1%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 110.2 to Rs 276.8, registering a gain of Rs 166.6 (up 151.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,804.5 to 43,710.8, registering a gain of 57.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 132.0%), GRANULES INDIA (up 131.0%) and Glenmark Pharma (up 125.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,984.0 (down 0.3%).

The top losers among the BSE Sensex today are SBI (down 1.3%) and Ultratech Cement (down 0.8%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 25,138.0 . SBI and Coal India are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,628.1 to 81,984.0, registering a gain of 16,355.8 points (up 24.9%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 37.6.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 7%; BSE HEALTHCARE Index Up 0.3%". Click here!